Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Cytokine Release Syndrome × siltuximab × Clear all

Phase

Status

Recruiting 2 Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thrombocytosis 1 Thrombocytopenia 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Multiple Myeloma 1 Lymphoma, Follicular 1 Kidney Neoplasms 1 Cytokine Release Syndrome 1 Carcinoma, Renal Cell 1 Anemia 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06352866 2025-03-03

Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to tx w/ Teclistamab in RRMM

Case Comprehensive Cancer Center

Phase 2 Withdrawn

Cytokine Release Syndrome, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡